SG11202011369VA - Blood biomarkers of stroke - Google Patents
Blood biomarkers of strokeInfo
- Publication number
- SG11202011369VA SG11202011369VA SG11202011369VA SG11202011369VA SG11202011369VA SG 11202011369V A SG11202011369V A SG 11202011369VA SG 11202011369V A SG11202011369V A SG 11202011369VA SG 11202011369V A SG11202011369V A SG 11202011369VA SG 11202011369V A SG11202011369V A SG 11202011369VA
- Authority
- SG
- Singapore
- Prior art keywords
- stroke
- blood biomarkers
- biomarkers
- blood
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18305600 | 2018-05-16 | ||
PCT/EP2019/062653 WO2019219831A1 (en) | 2018-05-16 | 2019-05-16 | Blood biomarkers of stroke |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202011369VA true SG11202011369VA (en) | 2020-12-30 |
Family
ID=62386311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202011369VA SG11202011369VA (en) | 2018-05-16 | 2019-05-16 | Blood biomarkers of stroke |
Country Status (12)
Country | Link |
---|---|
US (1) | US20210214793A1 (en) |
EP (1) | EP3794355A1 (en) |
JP (1) | JP7463351B2 (en) |
KR (1) | KR20210049026A (en) |
CN (1) | CN112424609A (en) |
AU (1) | AU2019270404A1 (en) |
BR (1) | BR112020023259A2 (en) |
CA (1) | CA3100171A1 (en) |
MA (1) | MA52617A (en) |
MX (1) | MX2020012297A (en) |
SG (1) | SG11202011369VA (en) |
WO (1) | WO2019219831A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020154398A1 (en) * | 2019-01-22 | 2020-07-30 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Noninvasive real-time patient-specific assessment of stroke severity |
CN114107487B (en) * | 2021-12-23 | 2024-01-09 | 太原市精神病医院 | Product for diagnosing cerebral apoplexy |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
WO2003008647A2 (en) * | 2000-11-28 | 2003-01-30 | University Of Cincinnati | Blood assessment of injury |
US9005891B2 (en) | 2009-11-10 | 2015-04-14 | Genomic Health, Inc. | Methods for depleting RNA from nucleic acid samples |
US9410204B2 (en) * | 2012-01-07 | 2016-08-09 | The Regents Of The University Of California | Biomarkers for diagnosing ischemia |
WO2014120731A1 (en) | 2013-02-01 | 2014-08-07 | West Virginia University | A biomarker algorithm for determining the time of stroke symptom onset and method |
WO2015054700A2 (en) * | 2013-10-13 | 2015-04-16 | The Research Foundation For Suny | Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof |
CA2992139A1 (en) * | 2015-07-10 | 2017-01-19 | West Virginia University | Markers of stroke and stroke severity |
WO2018067571A2 (en) * | 2016-10-03 | 2018-04-12 | West Virginia University | Computer implemented discovery of biomarkers for blood brain barrier disruption |
-
2019
- 2019-05-16 MA MA052617A patent/MA52617A/en unknown
- 2019-05-16 WO PCT/EP2019/062653 patent/WO2019219831A1/en unknown
- 2019-05-16 US US17/054,820 patent/US20210214793A1/en active Pending
- 2019-05-16 SG SG11202011369VA patent/SG11202011369VA/en unknown
- 2019-05-16 MX MX2020012297A patent/MX2020012297A/en unknown
- 2019-05-16 JP JP2021514483A patent/JP7463351B2/en active Active
- 2019-05-16 CN CN201980047566.0A patent/CN112424609A/en active Pending
- 2019-05-16 CA CA3100171A patent/CA3100171A1/en active Pending
- 2019-05-16 EP EP19723441.2A patent/EP3794355A1/en active Pending
- 2019-05-16 KR KR1020207035973A patent/KR20210049026A/en unknown
- 2019-05-16 BR BR112020023259-9A patent/BR112020023259A2/en unknown
- 2019-05-16 AU AU2019270404A patent/AU2019270404A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021523744A (en) | 2021-09-09 |
CA3100171A1 (en) | 2019-11-21 |
JP7463351B2 (en) | 2024-04-08 |
CN112424609A (en) | 2021-02-26 |
BR112020023259A2 (en) | 2021-02-23 |
US20210214793A1 (en) | 2021-07-15 |
AU2019270404A1 (en) | 2020-12-10 |
MA52617A (en) | 2021-03-24 |
WO2019219831A1 (en) | 2019-11-21 |
EP3794355A1 (en) | 2021-03-24 |
KR20210049026A (en) | 2021-05-04 |
MX2020012297A (en) | 2021-03-25 |
AU2019270404A2 (en) | 2020-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL268731A (en) | New uses of anti-sirpg antibodies | |
GB201719639D0 (en) | Setection of biomarkers | |
IL262623B2 (en) | Tourniquet | |
SG11202011369VA (en) | Blood biomarkers of stroke | |
IL268187A (en) | Use of senicapoc for treatment of stroke | |
EP3635402A4 (en) | Biomarker of disease | |
IL276107A (en) | Solid forms of fasoracetam | |
EP3794361C0 (en) | State analysis of an inductive operating resource | |
SG11202105136WA (en) | Application of chidamide | |
GB2579122B (en) | Tissue analysis | |
GB201721723D0 (en) | Biomarkers of impaired health | |
IL281882A (en) | Microdosing | |
AU2018903745A0 (en) | Biomarkers of disease | |
GB201811451D0 (en) | Blood analysis | |
AU2017905180A0 (en) | Biomarker of disease | |
CA190045S (en) | Portion of an insole | |
CA189475S (en) | Portion of an insole | |
GB201808489D0 (en) | Novel biomarkers | |
GB201808400D0 (en) | Novel biomarkers | |
AU2017901921A0 (en) | Biomarker of disease | |
GB201809872D0 (en) | Biomarkers | |
GB201809868D0 (en) | Biomarkers | |
GB201809854D0 (en) | Biomarkers | |
GB201809882D0 (en) | Biomarkers | |
GB201809885D0 (en) | Biomarkers |